Chemplast Sanmar Limited has informed the Exchange about Investor Presentation
CHEMPLASTS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Chemplast Sanmar reported a challenging FY '26 with consolidated revenue of INR 4,224 crores (down 3% YoY) and EBITDA of INR 198 crores (down 10% YoY), resulting in a net loss of INR 280 crores. The company took a significant non-cash impairment charge of INR 898 crores on its investment in subsidiary CCVL due to severe margin pressure in the Suspension PVC segment from low-cost Chinese imports and volatile VCM prices triggered by the Middle East crisis. The Specialty Chemicals segment performed steadily with Paste PVC showing improved realisations, CMCD reporting 45+ molecules in pipeline, and R32 refrigerant gas commencing commercial production in May 2026. The Board has constituted a committee of Independent Directors to evaluate strategic priorities including potential M&A opportunities.
The massive impairment charge and losses reflect severe stress in the commodity chemicals business, but the specialty chemicals growth trajectory and new R32 production provide long-term upside. The strategic review committee suggests potential restructuring or acquisitions ahead, which could unlock shareholder value.